MoneyWorks4Me

Novelix Pharma - Quaterly Results

27 May 2025 Evaluate
The total revenue hovered 2374.61% to Rs. 208.61 millions for the March 2025 quarter as against Rs. 8.43 millions during the corresponding quarter last year.Profit after Tax for the quarter ended March 2025 saw a decline of -33.94% from Rs. 2.77 millions to Rs. 1.83  millions.Operating profit for the quarter ended March 2025 decreased to 2.34 millions as compared to 2.84 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 208.61 8.43 2374.61 307.18 42.24 627.23 307.18 42.24 627.23
Other Income 0.00 1.29 0.00 0.16 3.07 -94.79 0.16 3.07 -94.79
PBIDT 2.34 2.84 -17.61 1.60 0.60 166.67 1.60 0.60 166.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.34 2.84 -17.61 1.60 0.60 166.67 1.60 0.60 166.67
Depreciation 0.23 0.06 283.33 0.38 0.38 0.00 0.38 0.38 0.00
PBT 2.11 2.78 -24.10 1.22 0.22 454.55 1.22 0.22 454.55
TAX 0.28 0.01 2700.00 0.39 0.11 254.55 0.39 0.11 254.55
Deferred Tax -0.02 0.01 -300.00 0.09 0.11 -18.18 0.09 0.11 -18.18
PAT 1.83 2.77 -33.94 0.83 0.11 654.55 0.83 0.11 654.55
Equity 99.50 81.00 22.84 99.50 81.00 22.84 99.50 81.00 22.84
PBIDTM(%) 1.12 33.69 -96.67 0.52 1.42 -63.33 0.52 1.42 -63.33
Peers